Pricing
Pricing

Reata Pharmaceuticals

COMPARE

Overview

Total Funding Amount 
$468.9M
CB Rank (Company) 
15,042
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation and neurodegenerative diseases.
Categories 
Biopharma, Biotechnology, Pharmaceutical
Headquarters Regions 
Dallas/Fort Worth Metroplex, Southern US
Founded Date 
2002
Founders 
Warren Huff
Operating Status 
Active
Funding Status 
IPO
Last Funding Type 
Post-IPO Debt
Number of Employees 
51-100
Legal Name 
Reata Pharmaceuticals, Inc.
IPO Status 
Public
Stock Symbol 
NASDAQ:RETA
Website 
www.reatapharma.com
LinkedIn 
View on LinkedIn
Twitter 
View on Twitter
Contact Email 
info@reatapharma.com
Phone Number 
972-865-2219

Reata Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs for cancer, inflammation, and neurodegenerative diseases. It offers antioxidant inflammation modulating drugs, as well as drugs that correct protein misfolding. The company also develops drugs for the treatment of renal/cardiovascular and autoimmune diseases. The company was formerly known as Reata Discovery, Inc. and changed its name to Reata Pharmaceuticals, Inc. in May 2005. The company was founded in 2002 and is based in Irving, Texas.

Read More

Find your next opportunity with Crunchbase Pro + Data Boost

  • Advanced Search - Find prospects with 200+ premium search filters
  • Premium Insights - View competitors, tech stack, IT spend and more
  • Monitor & Track - Get automatic email alerts on opportunities

IPO & Stock Price

Reata Pharmaceuticals is registered under the ticker NASDAQ:RETA
. Their stock opened with $11.00 in its May 26, 2016 IPO.
Stock Symbol 
NASDAQ:RETA
Money Raised at IPO 
$60.5M
IPO Share Price 
$11.00
IPO Date 
May 26, 2016

Funding Rounds

Number of Funding Rounds 
7
Total Funding Amount 
$468.9M
Reata Pharmaceuticals has raised a total of $468.9M in funding over 7 rounds. Their latest funding was raised on Apr 3, 2017 from a Post-IPO Debt round.

Investors

Related Hubs

Company Tech Stack by Siftery

Reata Pharmaceuticals uses 15 technology products and services including Google AnalyticsWordPress, and Vimeo.

Mobile App Metrics by Apptopia

App Name  
App Store  
Monthly Downloads  
Alport Study
Google Play
Alport Study
Itunes Connect
PHOENIX Study
Google Play
MOXIe
Google Play
MOXIe Study
Itunes Connect
PHOENIX Study
Itunes Connect

Website Tech Stack by BuiltWith

Reata Pharmaceuticals is actively using 42 technologies for its website. These include Viewport MetaIPhone / Mobile Compatible, and SPF.

Web Traffic by SimilarWeb

Reata Pharmaceuticals is ranked 2,327,091 among websites globally based on its 6,762 monthly web visitors.

Patents and Trademarks by IPqwery

The intellectual property of Reata Pharmaceuticals includes 50 registered patents primarily in the 'Organic Chemistry' category. Additionally, Reata Pharmaceuticals has registered 4 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products'.

Interest Signals by Bombora

Reata Pharmaceuticals employees are showing high interest in Shop.orgDigital Assessment, and Transperfect Inc.

Competitors & Revenue by Owler

IT Spend by Aberdeen

Current Team

Number of Current Team Members 
2
Reata Pharmaceuticals has 2 current team members, including Chief Legal Officer Michael Wortley.
Michael Wortley
Chief Legal Officer
Warren Huff
Founding Chief Executive Officer and President

Board Members and Advisors

Number of Board Members / Advisors 
3
Reata Pharmaceuticals has 3 board members and advisors, including Jack B. Nielsen.
Jack B. Nielsen
Board Member
Dennis Stone
Board Member
Nancy Wysenski
Board Member

Past Team

Number of Past Team Members 
1
Reata Pharmaceuticals has 1 past team member, Vice President of Commercial Analysis Michael Kenston.
Person Name  
Title At Company  
Start Date  
End Date  
Michael Kenston
Vice President of Commercial Analysis

Recent News & Activity

Number of Articles 
26
Date
Activity

Twitter

Sign up for a free Crunchbase account to follow and track profiles you care about.


Terms of Service | Privacy Policy | © 2019 Crunchbase Inc. All Rights Reserved.